MSKCC (Motzer) Metastatic RCC Risk
MSKCC (Motzer) Metastatic RCC Risk - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
Open the MSKCC (Motzer) Metastatic RCC Risk → Runs in your browser. No signup, no tracking.
What this is
MSKCC (Motzer) Metastatic RCC Risk is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. MSKCC (Motzer) Metastatic RCC Risk - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
When to use it
Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.
References
Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol. 1999;17(8):2530-2540. Read the source ↗
Worked example: MSKCC: 2 factors — intermediate risk (median OS 10 mo).
Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.